您的位置: 首页 > 文字全文
2023年7月 第38卷 第7期11
目录

乙型肝炎病毒感染患者并发2型糖尿病风险因素分析

Analysis of Risk Factors for Type 2 Diabetes in Patients with Hepatitis B Virus Infection

来源期刊: 广州医药 | - 发布时间: 收稿时间:2026/6/4 9:45:07 阅读量:23
作者:
关键词:
乙型肝炎病毒;2型糖尿病;体重指数;风险因素
Hepatitis B virus; Type 2 diabetes; Body mass index; Risk factors
DOI:
收稿时间:
 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 分析乙型肝炎病毒(HBV)感染患者并发2型糖尿病(T2DM)相关风险因素。方法 研究收集2024年1月~2025年5月期间,于周口市传染病医院(周口市结核病防治所、周口市第五人民医院)接受治疗的HBV感染患者临床资料,共纳入患者95例,根据HBV感染后是否并发T2DM分组,合并T2DM患者纳入并发组(n=21),非合并T2DM患者纳入对照组(n=74),比较两组患者基线资料及实验室检查数据,逻辑回归分析HBV感染患者并发T2DM风险因素。结果 并发组年龄、体重指数(BMI)、甘油三酯(TG)高于对照组(P<0.05),年龄≥45岁、BMI肥胖、HBV感染时间≥6个月、TG≥1.7mmol/L、吸烟、乙型肝炎表面抗原(HBsAg)阳性及纤维化-4(FIB-4)指数≥2.67例数占比高于对照组(P<0.05)。年龄≥45岁[OR=21.599(95%CI:2.875-162.262)]、BMI(肥胖)[OR=16.729(95%CI:1.443-193.981)]、HBV感染时间≥6个月[OR=6.199(95%CI:1.101-34.904)]、吸烟[OR=9.429(95%CI:1.344-66.141)]、TG≥1.7mmol/L[OR=71.834(95%CI:7.060-730.897)]是HBV感染患者并发T2DM危险因素(P<0.05)。结论 HBV感染患者并发T2DM受人口学特征年龄、BMI、临床病程HBV感染时间、共病血脂异常及生活方式吸烟的共同影响。
Abstract: Objective To analyze risk factors associated with the development of type 2 diabetes mellitus (T2DM) in patients with hepatitis B virus (HBV) infection. Methods Clinical data were collected from HBV-infected patients treated at the Zhoukou City Infectious Disease Hospital (Zhoukou City Tuberculosis Prevention and Control Institute)between January 2024 and May 2025. A total of 95 patients were included in the study, Patients were grouped based on the presence or absence of T2DM following HBV infection. Patients with T2DM were included in the T2DM group (n=21), while those without T2DM were included in the control group (n=74). Baseline characteristics and laboratory test data were compared between the two groups, and logistic regression analysis was performed to identify factors associated with the development of T2DM in HBV-infected patients. Results The age, body mass index (BMI), and triglycerides (TG) in the intervention group were higher than those in the control group (P < 0.05); The proportion of cases with age ≥45 years, obese BMI, HBV infection duration ≥6 months, TG ≥1.7 mmol/L, smoking, hepatitis B surface antigen (HBsAg) positivity, and a FIB-4 score ≥2.67 was higher than that in the control group (P < 0.05). Age ≥ 45 years [OR = 21.599 (95% CI: 2.875–162.262)], BMI (obesity) [OR = 16.729 (95% CI: 1.443–193.981)], duration of HBV infection ≥ 6 months [OR = 6.199 (95% CI: 1.101–34.904)], smoking [OR=9.429 (95% CI: 1.344–66.141)], and TG ≥ 1.7 mmol/L [OR=71.834 (95% CI: 7.060–730.897)] were risk factors for T2DM in patients with HBV infection (P < 0.05). Conclusion The development of T2DM in patients with HBV infection is influenced by a combination of demographic factors (age and BMI), clinical course (duration of HBV infection), comorbid dyslipidemia, and lifestyle factors (smoking).
1、 参考文献 [1] Konings L A M, Miguela Ez-Matute L, Boeren A M P, et al. Pharmacological treatment options for metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus: A systematic review[J]. European journal of clinical investigation, 2025,55(4):e70003. [2] Giangregorio F, Mosconi E, Debellis M G, et al. A Systematic Review of Metabolic Syndrome: Key Correlated Pathologies and Non-Invasive Diagnostic Approaches[J]. Journal of clinical medicine, 2024,13(19):5880. [3] 余博容, 陈源文. 慢性HBV感染与代谢功能障碍基础研究:当前进展与争议[J]. 临床肝胆病杂志, 2024,40(03):446-452. [4] Liu X, Zhou Y. Influence of hepatitis?B virus on the prevalence of diabetes complications in patients with type?2 diabetes[J]. Journal of diabetes investigation, 2023,14(3):429-434. [5] 李维丹, 石小霞, 何竞月. 妊娠期糖尿病合并HBV感染与妊娠结局研究进展[J]. 病毒学报, 2025,41(01):257-263. [6] Li H, Hou Y, Xin W, et al. The efficacy of sodium-glucose transporter 2 inhibitors in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis[J]. Pharmacological research, 2025,213:107647. [7] 陈恩富, 崔富强, 党双锁, 等. 成人乙型肝炎病毒感染筛查、检测及管理专家建议[J]. 临床肝胆病杂志, 2024,40(08):1543-1550. [8] 李易书东, 陈兆峰. 1990—2021年全球归因于高身体质量指数的乙肝疾病负担分析[J]. 中国循证医学杂志, 2026,26(02):139-146. [9] 徐祥瑞, 金昱, 徐淑静, 等. 靶向HBV cccDNA生成和转录的小分子调控剂研究进展[J]. 药学学报, 2023,58(10):2979-2994. [10] 朱政全, 梁斌, 石明连, 等. 乙型肝炎病毒通过自分泌运动因子/溶血磷脂酸信号损伤对糖稳态的作用及其机制研究[J]. 中国现代医学杂志, 2024,34(16):17-25. [11] 曲建昌, 窦京涛, 王安平, 等. 脂肪肝指数与不同糖代谢人群新发糖尿病风险相关性的研究[J]. 中国糖尿病杂志, 2024,32(10):726-730. [12] 侯杰, 贺成军, 丁芸发, 等. 1990—2021年中国因低体力活动导致的2型糖尿病疾病负担评估及未来趋势预测[J]. 疾病监测, 2026:1-11. [13] 白雯文, 包含. TyG在体质量指数与糖尿病发生风险间的中介效应[J]. 中华疾病控制杂志, 2025,29(12):1467-1472. [14] Guo R, Wei L, Cao Y, et al. Normal triglyceride concentration and the risk of diabetes mellitus type 2 in the general population of China[J]. Frontiers in endocrinology, 2024,15:1330650. [15] 何梦如, 徐晓莉, 赵根明, 等. 成年居民生活方式与2型糖尿病发病风险关联的前瞻性研究[J]. 复旦学报(医学版), 2025,52(05):647-656. [16] 邹玉萍, 姚莉, 邹军, 等. 高代谢风险慢性乙型肝炎患者发生肝硬化的影响因素分析及预测模型构建[J]. 临床肝胆病杂志, 2025,41(06):1105-1112.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录